A Study to Compare Two Formulations of Xylometazoline/Dexpanthenol Nasal Spray for the Treatment of Nasal Congestion.

NCT03439436 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Nasal Congestion

Interventions

DRUG: xylo+dex nasal spray (0.1 mg+5 mg/dose)
DRUG: Nasic

Sponsor

McNeil AB